These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 891213)

  • 21. The use of diazoxide in hypertensive crises with particular reference to the control of hypertension in severe renal failure.
    Mathew TH; Kincaid-Smith P
    Drugs; 1971; 2(2):73-7. PubMed ID: 5139210
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of the hypertensive crises. Experience with diazoxide].
    Ocón Pujadas J; Herrera Pérez de Villar J; Belvis Mompel JJ; García Muñóz P
    Rev Clin Esp; 1975 Mar; 136(5):473-82. PubMed ID: 1135461
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of levosimendan on systemic and regional hemodynamics in septic myocardial depression.
    Creteur J; Bouckaert Y; Mélot C; Vincent JL
    Intensive Care Med; 2006 May; 32(5):790; author reply 791-2. PubMed ID: 16555067
    [No Abstract]   [Full Text] [Related]  

  • 24. [Vasodilating agents in the treatment of hypertension - a review].
    Andersson O
    Lakartidningen; 1981 Jan; 78(5):352-6. PubMed ID: 6259465
    [No Abstract]   [Full Text] [Related]  

  • 25. Hope in primary pulmonary hypertension.
    Reeves JT
    N Engl J Med; 1980 Jan; 302(2):112-3. PubMed ID: 7350416
    [No Abstract]   [Full Text] [Related]  

  • 26. [Pharmacologic aspects of reactions of the cardiac circulation to drugs].
    Zakusov VV
    Vestn Akad Med Nauk SSSR; 1963; 18(1):3-9. PubMed ID: 5889334
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of anesthetics and cardiovascular agents on blood circulation].
    Shimizu R
    Kokyu To Junkan; 1973 Jul; 21(7):608-10. PubMed ID: 4737819
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hemodynamic effect of certain vasodilators on the major and lesser circulation].
    Romoda T
    Orv Hetil; 1988 Aug; 129(34):1791-6. PubMed ID: 3140174
    [No Abstract]   [Full Text] [Related]  

  • 29. Diazoxide: a review of its pharmacological properties and therapeutic use in hypertensive crises.
    Drugs; 1971; 2(2):78-137. PubMed ID: 4336104
    [No Abstract]   [Full Text] [Related]  

  • 30. Acute haemodynamic effects of endralazine in patients with coronary artery disease and stable angina pectoris.
    van der Wall EE; de Feyter PJ; Res JC; Roos JP; van Engelen CL
    Postgrad Med J; 1983; 59 Suppl 3():42-4. PubMed ID: 6647210
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prizidilol in essential hypertension: long-term effects on plasma volume, extracellular fluid volume, and central hemodynamics at rest and during exercise.
    Lund-Johansen P; Omvik P
    J Cardiovasc Pharmacol; 1982; 4(6):1012-7. PubMed ID: 6185765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patterns of cerebral dysautoregulation in severe hypertension to blood pressure reduction with diazoxide.
    Goldberg HI; Codario RA; Banka RS; Reivich M
    Acta Neurol Scand Suppl; 1977; 64():64-5. PubMed ID: 268910
    [No Abstract]   [Full Text] [Related]  

  • 33. [Pharmacodynamic study of a new vasodilator, cinepazide maleate I -Vasodilating action].
    Pourrias B; Bouvet P; Raynaud G
    Therapie; 1974; 29(1):29-41. PubMed ID: 4849379
    [No Abstract]   [Full Text] [Related]  

  • 34. [Effects of cadralazine (ISF 2469) on water-sodium balance and on essential arterial hypertension].
    Lavezzaro GC; Gastaldo D; Noussan P; Bensoni M; Parini J; Angelino PF
    Minerva Cardioangiol; 1981 Oct; 29(10):527-34. PubMed ID: 7322375
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of korvaton and korinfar on systemic circulation in heart failure patients].
    Koshlia VI
    Vrach Delo; 1986 Aug; (8):23-5. PubMed ID: 3776152
    [No Abstract]   [Full Text] [Related]  

  • 36. Vasodilator therapy in primary pulmonary hypertension.
    Elkayam U
    Chest; 1981 Mar; 79(3):253-4. PubMed ID: 7471853
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacodynamic and pharmacokinetic studies with the vasodilator endralazine.
    Elliott HL; Meredith PA; Reid JL
    J Hypertens Suppl; 1984 Dec; 2(3):S551-4. PubMed ID: 6599716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The influence of vasodilating beta-blockers on cardiac function and vascular resistance in essential hypertension.
    Lund-Johansen P
    Clin Nephrol; 1992; 38 Suppl 1():S78-86. PubMed ID: 1363538
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dose-response curve and time course of the antihypertensive effect of SKF 92 657, a beta-receptor-blocking and vasodilating compound.
    Leonetti G; Terzoli L; Sala C; Bianchini C; Zanchetti A
    Clin Sci (Lond); 1980 Dec; 59 Suppl 6():461s-463s. PubMed ID: 6108817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diazoxide disposition and effect on vascular resistance and compliance in dogs.
    Ogilvie RI
    Hypertension; 1981; 3(2):225-32. PubMed ID: 7216377
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.